Nanomaterials international convention is designed to offer diverse and cutting-edge training as a way to hold Nanotechnology experts to be updated with the improvements which can be taking place within the discipline of Nanotechnology, The convention will be organized with a subject matter “Exploring new ideas in the field of Nanomaterials and Nanotechnology”.
NANOSAFETY: FUTURE-PROOFING INDUSTRY INNOVATION
Interactions between colloidal particles and macromolecules occur in material processing, pharmacy, nanoparticle synthesis, and many other fields. This Zsigmondy colloquium will cover the entire colloidal science and put a focus on particle-polymer combinations.
The 13th Zsigmondy colloquium of the German Colloid Society aims at younger researchers at the pre- and post-doc levels. Our goal is to foster communication between young scientists, senior colleagues, and participants from industry and small enterprises.
A number of H2020 funded projects are working on various aspects of the Safe-by-Design (SbD) concept and all rely upon industry to understand its meaning and how to use the tools being developed in these projects. Disseminating this knowledge to a wider audience will help in the acceptance and uptake of SbD by companies and will also allow the projects to learn more about stakeholder needs.
NIA and EuropaBio are pleased to host a joint webinar that present the opportunities and development pathways within nanomedicine.
Members from both networks will come together to understand how nanomaterials play a role across healthcare biotechnology applications, with examples of nanomedicines in development and clinical application. The webinar will also explore when regulatory worlds come together with healthcare and nano, and highlight funding opportunities for organisations to work together in developing novel nanomedicines.
NIA hosts its second 2017 webinar that focuses on current regulatory priorities and activities open for member feedback at national and international level.
The first 2017 webinar in February saw Regulatory Affairs Director David Carlander discuss with members around topics including the nanoform testing and national directories. On May 24, the webinar will discuss all currently relevant topics, including REACH annex modification and nanomaterial definitions. Members will be notified of initial agenda in May and can nominate topics of importance for inclusion.
Medical Nanotechnology 2017 provides a perfect symposium for scientists, engineers, directors of companies and students in the field of Nanotechnology to meet and share their knowledge. The scientific program paves a way to gather visionaries through the research talks and presentations and put forward many thought provoking strategies.
NIA Member webinar: Toxic substances Control Act (TSCA) implementation and current US regulatory environment
Impact on commercialization.
This webinar is dedicated to analysis of the January EPA ruling for the Toxic Substances Control Act (TSCA), coming into force May 2017. Hosted in partnership with NIA member Bergeson & Campbell PC, the agenda includes:
The New Trump EPA Administration
EPA Under Pruitt and What does it Mean for Chemical Management?
Building on the success of the 2015 symposium held at Legend Safari Lodge, Limpopo Province, South Africa, this conference will also bring together a multidisciplinary cross section of delegates from different scientific areas specializing in all aspects of nanosafety.